logo
Measles in Liverpool: Call to 'get everyone fully vaccinated'

Measles in Liverpool: Call to 'get everyone fully vaccinated'

BBC News17-07-2025
The leader of Liverpool City Council has vowed to ensure "we get everyone fully vaccinated" against measles following the death of a child who had contracted the highly contagious disease.Liam Robinson said the local authority extended its "deepest sympathies and heartfelt condolences" to the family of the unidentified child, who died on Sunday at Alder Hey Children's Hospital.Health bosses said measles was on the rise among young people in the area, with a surge in "seriously unwell" children being admitted to hospital.Robinson said the Labour-run council would do its utmost to improve the uptake of vaccines in the city.
The Alder Hey case was the second death due to an acute measles infection in Great Britain this decade, the Local Democracy Reporting Service said.No official details have been released either about the latest child's vaccination status or whether they were also being treated for other conditions.The Sunday Times reported the child was ill with measles and other health issues.Since June, Alder Hey said it had treated 17 children with measles.In Liverpool, the take-up rate for having both doses of the measles, mumps and rubella (MMR) vaccine stands at about 74%, significantly lower than the 83% rate for England as a whole.To achieve herd immunity, the World Health Organization wants 95% of the population to be double-jabbed.Earlier this week, Liverpool's director of public health said he was very concerned about the spread of measles.In some areas of the city, Prof Matt Ashton said he believed vaccination rates were even lower, increasing fears of a major measles outbreak.His counterpart in Wirral, Dave Bradburn, confirmed on Tuesday that his borough had recorded a case of measles involving a young child.
Listen to the best of BBC Radio Merseyside on Sounds and follow BBC Merseyside on Facebook, X, and Instagram. You can also send story ideas via Whatsapp to 0808 100 2230.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

‘Doctors thought I had a stroke after Botox injection'
‘Doctors thought I had a stroke after Botox injection'

The Independent

time4 minutes ago

  • The Independent

‘Doctors thought I had a stroke after Botox injection'

Nicola Fairley is one of 38 cases of botulism so far linked to unlicensed anti-wrinkle injections in recent outbreak of disease many doctors have never treated. Fairley was left unable to swallow and doctors thought she had suffered a stroke after contracting the life-threatening illness from a potentially illegal product. The botox was administered by her usual beautician after she won a Facebook competition. Botulism symptoms include slurred speech, breathing problems and can be deadly, it's so rare many doctors never see it in their entire careers.

UK-India trade deal sparks fears over access to cheap medicines for millions
UK-India trade deal sparks fears over access to cheap medicines for millions

ITV News

time34 minutes ago

  • ITV News

UK-India trade deal sparks fears over access to cheap medicines for millions

A newly signed trade agreement between India and the UK has triggered concerns that millions of poor Indians may lose access to affordable life-saving medicines. Civil society groups and health experts say the UK-India Free Trade Agreement (FTA), finalised between two countries, tilts the balance in favour of multinational pharmaceutical corporations and threatens to erode long-standing protections that have allowed India to produce low-cost generic drugs. 'This is not just about trade. It's about whether a person living on ₹200 (£2) a day can afford cancer treatment or survive tuberculosis,' said Jyotsna Singh, co-convenor of the Working Group on Access to Medicines and Treatments. At the heart of the controversy are the agreement's intellectual property (IP) provisions, which activists say may restrict the Indian government's ability to issue compulsory licences—legal tools that allow domestic companies to manufacture patented drugs at reduced prices during public health emergencies. India used this provision in 2012 to dramatically cut the price of sorafenib, a cancer drug sold by Bayer under the brand Nexavar. Generic versions slashed the monthly cost by nearly 97%, from ₹2.8 lakh (£2,600) to around ₹8,800 (£80), making it affordable to thousands. 'By discouraging compulsory licensing and promoting voluntary licences, the deal hands over control of access to medicines to the market,' said Prof Biswajit Dhar, a trade expert and former professor at New Delhi's Jawaharlal Nehru University. 'Voluntary licences often come with strings attached and don't bring the same price reductions.' Weakening India's Patent Safeguards Under the FTA, companies will no longer need to report annually how their patents are being 'worked'—or used—in India. Instead, disclosures can be made every three years, and some information can be kept confidential. Activists say this undermines transparency and makes it harder to prove that a drug isn't available to the public, a key step in applying for a compulsory licence. There are also concerns the deal could open the door to 'evergreening'—a tactic in which companies make minor changes to existing drugs and claim new patents. Indian law currently limits this practice under Section 3(d) of the Patents Act, but experts warn the FTA's emphasis on 'harmonisation' of IP standards with Western countries could override such protections. 'This is effectively a backdoor entry for TRIPS-plus provisions,' said K.M. Gopakumar, co-convenor of the Working Group. 'It would push India to grant unnecessary patents, prolonging monopolies and delaying cheaper alternatives.' The Indian pharmaceutical industry supplies more than 60% of global vaccines and a significant share of affordable generics to low- and middle-income countries. Critics say the FTA may limit this capacity and ultimately have consequences well beyond India's borders. Government response The Indian government has promoted the FTA as a landmark deal that will boost exports and attract UK investment in manufacturing, services, and digital trade. Officials insist that India has preserved its ability to protect public health. But rights groups remain unconvinced. 'You cannot negotiate away access to life-saving drugs in the name of free trade,' said Gargeya Telakapalli, a public health campaigner based in Hyderabad. 'The poorest Indians—those with cancer, HIV, diabetes, or TB—are being quietly sacrificed.' Broader implications The deal follows a similar agreement India signed last year with the European Free Trade Association (EFTA), which also faced criticism for diluting IP safeguards. Observers say the trend may reflect a shift in India's trade policy as it seeks closer ties with Western economies. But for many in India's healthcare and legal communities, the question remains: how much access to medicine is the country willing to give up for a better trade balance? From Westminster to Washington DC - our political experts are across all the latest key talking points. Listen to the latest episode below...

Health warning over counterfeit vodka made with medical-grade alcohol
Health warning over counterfeit vodka made with medical-grade alcohol

Metro

timean hour ago

  • Metro

Health warning over counterfeit vodka made with medical-grade alcohol

Health officials in Scotland have warned fans of Glen's vodka to keep an eye out for fake half bottles containing medical disinfectant. Scammers have hijacked the popular brand to sell counterfeit products containing the chemical isopropyl, which is typically used in hospital settings or in hand sanitiser. Food Standards Scotland (FSS) say the fake booze will smell and taste 'very different' to the Glen's product people recognise. Even small amounts of isopropyl can result in abdominal pain, vomiting, dizziness and headaches, they warned. Severe cases can leave drinkers in a coma or even dead. Genuine bottles of Glen's have a laser-etched code between the rear label and the base of the bottle which the fake bottles will not. More Trending Anyone concerned they might have drunk the counterfeit vodka, and who is experiencing symptoms, is urged to contact NHS 24 on 111 immediately. Glen's, one of the cheaper brands of vodka on the market, is a popular target for scammers. FSS has previously sent investigators to seize dozens of bottles of fake spirit using the same label from a shop in Coatbridge, Lanarkshire. And in September last year, the UK-wide Food Standards Agency sent out a warning about another fraud involving isopropyl alcohol in Glen's bottles. Get in touch with our news team by emailing us at webnews@ For more stories like this, check our news page. MORE: The one drink you should never order from a restaurant wine list MORE: How a generation-bending TikTok campaign saved a local boozer MORE: Forget about Prosecco — drink this £6.97 sparkling wine from Asda instead

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store